Viral Vector Contract Development Manufacturing Organizations Market, By Vector Type (Adenovirus, Lentivirus, Adeno-associated Virus, Retrovirus, Herpes Simplex Virus, and Hybrid/Chimeric Vectors), By Workflow Stage, By Scale, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4293
|
Published Date
August 2025
|
Pages
378
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Viral Vector Contract Development Manufacturing Organizations Market size was valued at US$ 1,123 Million in 2024, expanding at a CAGR of 18.5% from 2025 to 2032.
The Viral Vector Contract Development and Manufacturing Organizations (CDMO) Market centers on providing outsourced manufacturing services for viral vectors used in gene therapies, vaccines, and cell-based treatments. With over 30 gene therapy approvals worldwide by mid-2024 and a growing pipeline of AAV, lentiviral, and adenoviral vector clinical trials, demand for specialized manufacturing capacity is surging. Increased investments from pharmaceutical and biotechnology companies are driving CDMOs to expand operations, exemplified by Thermo Fisher Scientific’s $650 million investment in 2023 to enhance its cell and gene therapy manufacturing network. However, challenges such as high production costs, complex bioprocessing requirements, and stringent regulatory oversight concerning viral safety and consistency could hinder growth. Despite these obstacles, opportunities are rising through strategic partnerships, platform standardization, and increasing demand from regions with limited domestic vector manufacturing capabilities.
Viral Vector Contract Development Manufacturing Organizations Market- Market Dynamics
Expanding Gene Therapy Pipeline and Increased Biotech Investments Drive Growth in the Viral Vector CDMO Market
The rapid expansion of gene therapy pipelines and increased biotech investments are driving significant growth in the viral vector CDMO market. As of 2024, over 2,000 gene therapy clinical trials are underway globally, according to the U.S. FDA and the Alliance for Regenerative Medicine. This surge has led major pharmaceutical companies to outsource viral vector production to specialized CDMOs to meet scalability, quality, and regulatory compliance requirements. In 2023, the U.S. Biomedical Advanced Research and Development Authority (BARDA) provided funding to expand domestic viral vector manufacturing, aiming to reduce dependence on overseas suppliers. Leading firms such as Catalent and Thermo Fisher Scientific have invested hundreds of millions of dollars to upgrade their viral vector production capabilities, addressing growing demand for AAV and lentiviral vectors in oncology and rare disease treatments. These trends highlight a strong move toward long-term CDMO partnerships and strategic capacity expansions across North America and Europe.
Viral Vector Contract Development Manufacturing Organizations Market- Segmentation Analysis:
The Global Viral Vector Contract Development Manufacturing Organizations Market is segmented on the basis of Vector Type, Workflow Stage, Scale, Application, and Region.
The gene therapy vectors market is segmented into six categories based on vector type: Adenovirus, Lentivirus, Adeno-associated Virus (AAV), Retrovirus, Herpes Simplex Virus, and Hybrid/Chimeric Vectors. Among these, Adeno-associated Virus (AAV) leads the market due to its established safety profile, high efficiency in gene delivery, and low immunogenicity, making it a preferred choice for a wide range of gene therapy applications. Following AAV, lentivirus vectors are favored for their ability to achieve stable gene integration, which is crucial for long-term therapeutic effects. Adenovirus vectors hold the third position, primarily used in vaccine development, including emerging infectious disease vaccines. Retrovirus, herpes simplex virus, and hybrid vectors cater to specialized niche therapies. According to the U.S. Food and Drug Administration (FDA), the number of gene therapy clinical trials utilizing AAV has increased by over 40% in the past five years, reflecting strong government support and regulatory frameworks encouraging the development of safe and effective viral vector-based therapies.
The market is also segmented based on workflow stages into Upstream Processing and Downstream Processing. Upstream processing dominates the market, focusing on cell culture techniques—particularly using HEK293 and Sf9 cells—and optimized transfection or infection protocols critical for scalable and high-yield vector production. These methods ensure consistent quality and quantity necessary for clinical and commercial applications. Downstream processing, which includes filtration, chromatography, ultracentrifugation, and final product formulation, plays a vital role in purifying the vectors, ensuring their stability, and meeting stringent clinical-grade quality standards. Filtration and chromatography are the primary purification methods, while ultracentrifugation and formulation guarantee product safety and efficacy. Government initiatives, such as the European Medicines Agency (EMA) and FDA’s guidelines on Good Manufacturing Practices (GMP) for gene therapies, continue to drive improvements in upstream and downstream processing technologies, ensuring reliable supply chains for advanced vector therapeutics.
Viral Vector Contract Development Manufacturing Organizations Market- Geographical Insights
North America holds a leading position in the viral vector CDMO market, supported by a strong biopharma ecosystem, substantial government funding, and advanced manufacturing infrastructure. In 2023, Thermo Fisher Scientific expanded its Maryland facility to increase AAV vector production capacity, while the U.S. FDA continued to fast-track gene therapy approvals. Europe also remains a key hub, with rising demand for contract manufacturing services in Germany, the UK, and the Netherlands. In June 2024, Catalent partnered with Oxford Biomedica to scale up viral vector manufacturing for European clients. Meanwhile, the Asia-Pacific region is rapidly emerging, led by China, Japan, and South Korea. Growing government support for cell and gene therapies is encouraging local CDMOs to enhance their capabilities. In 2024, Japan’s AGC Biologics announced a strategic partnership with a local gene therapy firm to establish viral vector production lines in Chiba, signaling strengthening regional capacity.
Viral Vector Contract Development Manufacturing Organizations Market- Competitive Landscape:
The market is marked by strategic expansions and acquisitions among leading players. Thermo Fisher Scientific is at the forefront, having acquired Brammer Bio in 2019 and Novasep’s Henogen division in January 2021 for approximately €725 million (~$875 million), significantly bolstering its viral vector footprint in Europe alongside its U.S. facilities in Lexington, Cambridge, Plainville, and Alachua. Catalent, which supports over half of FDA-approved new drugs in the past decade and produces around 70 billion doses annually across 50+ facilities, was acquired by Novo Holdings for $16.5 billion in December 2024, reshaping the contract manufacturing landscape across drug, gene therapy, and injection delivery sectors. Regional collaborations also intensify competition, such as Catalent’s partnerships with Sarepta Therapeutics and multiple COVID-19 vaccine manufacturers. These mergers, acquisitions, and alliances demonstrate increasing market differentiation through scale, global reach, and therapeutic specialization.
Recent Developments:
- In June 2025, ProBio inaugurated a 128,000 sq ft GMP facility in Hopewell, New Jersey, to produce plasmid DNA and viral vectors. The site plans to begin AAV manufacturing by Q3 2025 and lentiviral vector (LVV) services by Q1 2026.
- In May 2024, Charles River Laboratories launched a viral vector technology transfer program offering two frameworks—Fast Track for seamless transfers and Modular for customizable applications—to accelerate process handoffs to its Maryland Center of Excellence within nine months.
- In September 2024, Rentschler Biopharma introduced a comprehensive lentiviral vector manufacturing toolbox at its advanced therapies facility in Stevenage, UK. This complements its existing AAV services and includes process development, cGMP manufacturing, and a royalty-free HEK293 cell line designed to accelerate advanced therapy medicinal product (ATMP) production.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- AGC Biologics
- Aldevron
- Batavia Biosciences
- BioReliance (Merck KGaA)
- Catalent
- Charles River Laboratories
- Cobra Biologics (Charles River)
- FUJIFILM Diosynth Biotechnologies
- Genezen
- iBET
- Kaneka Eurogentec
- Lonza
- Novasep
- Oxford Biomedica
- REGENXBIO (CDMO Services arm)
- Thermo Fisher Scientific (Patheon)
- Vigene Biosciences (Charles River)
- VIVEbiotech
- WuXi Advanced Therapies
- Yposkesi
- Others
GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY VECTOR TYPE- MARKET ANALYSIS, 2019 - 2032
- Adenovirus
- Lentivirus
- Adeno-associated Virus
- Retrovirus
- Herpes Simplex Virus
- Hybrid/Chimeric Vectors
GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032
- Upstream Processing
- Cell culture (HEK293, Sf9)
- Transfection/infection protocols
- Downstream Processing
- Filtration & Chromatography
- Ultracentrifugation
- Final Product Formulation
GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY SCALE- MARKET ANALYSIS, 2019 - 2032
- Preclinical (R&D batches)
- Clinical (Phase I–III)
- Commercial (Market-ready supply)
GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Gene Therapy
- Cancer Immunotherapy
- Infectious Disease Vaccines
- Rare Disease Treatment
GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Viral Vector Contract Development Manufacturing Organizations Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Vector Type
2.1.2. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Workflow Stage
2.1.3. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Scale
2.1.4. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Application
2.1.5. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Country
2.1.6. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Region
2.2. Competitive Insights
3. Viral Vector Contract Development Manufacturing Organizations Key Market Trends
3.1. Viral Vector Contract Development Manufacturing Organizations Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Viral Vector Contract Development Manufacturing Organizations Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Viral Vector Contract Development Manufacturing Organizations Market Opportunities
3.4. Viral Vector Contract Development Manufacturing Organizations Market Future Trends
4. Viral Vector Contract Development Manufacturing Organizations Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Viral Vector Contract Development Manufacturing Organizations Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Viral Vector Contract Development Manufacturing Organizations Market Landscape
6.1. Viral Vector Contract Development Manufacturing Organizations Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Viral Vector Contract Development Manufacturing Organizations Market – By Vector Type
7.1. Overview
7.1.1. Segment Share Analysis, By Vector Type, 2024 & 2032 (%)
7.1.2. Adenovirus
7.1.3. Lentivirus
7.1.4. Adeno-associated Virus
7.1.5. Retrovirus
7.1.6. Herpes Simplex Virus
7.1.7. Hybrid/Chimeric Vectors
8. Viral Vector Contract Development Manufacturing Organizations Market – By Workflow Stage
8.1. Overview
8.1.1. Segment Share Analysis, By Workflow Stage, 2024 & 2032 (%)
8.1.2. Upstream Processing
8.1.2.1. Cell culture (HEK293, Sf9)
8.1.2.2. Transfection/infection protocols
8.1.3. Downstream Processing
8.1.3.1. Filtration & Chromatography
8.1.3.2. Ultracentrifugation
8.1.3.3. Final Product Formulation
9. Viral Vector Contract Development Manufacturing Organizations Market – By Scale
9.1. Overview
9.1.1. Segment Share Analysis, By Scale, 2024 & 2032 (%)
9.1.2. Preclinical (R&D batches)
9.1.3. Clinical (Phase I–III)
9.1.4. Commercial (Market-ready supply)
10. Viral Vector Contract Development Manufacturing Organizations Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Gene Therapy
10.1.3. Cancer Immunotherapy
10.1.4. Infectious Disease Vaccines
10.1.5. Rare Disease Treatment
11. Viral Vector Contract Development Manufacturing Organizations Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Viral Vector Contract Development Manufacturing Organizations Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. AGC Biologics
12.2.2. Aldevron
12.2.3. Batavia Biosciences
12.2.4. BioReliance (Merck KGaA)
12.2.5. Catalent
12.2.6. Charles River Laboratories
12.2.7. Cobra Biologics (Charles River)
12.2.8. FUJIFILM Diosynth Biotechnologies
12.2.9. Genezen
12.2.10. iBET
12.2.11. Kaneka Eurogentec
12.2.12. Lonza
12.2.13. Novasep
12.2.14. Oxford Biomedica
12.2.15. REGENXBIO (CDMO Services arm)
12.2.16. Thermo Fisher Scientific (Patheon)
12.2.17. Vigene Biosciences (Charles River)
12.2.18. VIVEbiotech
12.2.19. WuXi Advanced Therapies
12.2.20. Yposkesi
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
